News Aug 8, 2026
Kaizen Pharmaceuticals Secures Approval to Manufacture Cytotoxic Liquid Injectables
Building on the approval of our ๐๐ฒ๐ญ๐จ๐ญ๐จ๐ฑ๐ข๐ ๐๐ซ๐ฒ ๐๐จ๐ฐ๐๐๐ซ ๐๐ง๐ฃ๐๐๐ญ๐๐๐ฅ๐๐ฌ ๐ฌ๐๐๐ญ๐ข๐จ๐ง, Kaizen Pharmaceuticals (Pvt.) Ltd. is proud to have also received approval to manufacture ๐๐ฒ๐ญ๐จ๐ญ๐จ๐ฑ๐ข๐ ๐๐ข๐ช๐ฎ๐ข๐ ๐๐ง๐ฃ๐๐๐ญ๐๐๐ฅ๐๐ฌ through its advanced, high-tech Oncology manufacturing facility.
This approval enables the local aseptic production of ๐ซ๐๐๐๐ฒ-๐ญ๐จ-๐๐ข๐ฅ๐ฎ๐ญ๐ ๐จ๐ง๐๐จ๐ฅ๐จ๐ ๐ฒ ๐ญ๐ก๐๐ซ๐๐ฉ๐ข๐๐ฌ, helping widen patient access while reducing dependence on imported treatments and the associated foreign exchange burden.
Backed by stringent sterility, containment, and quality systems, this capability will support stronger affordability, supply continuity, and greater resilience in Pakistanโs oncology care landscape.
A proud achievement, bringing hope closer to cancer patients across Pakistan.